Erasca (ERAS) Shares Outstanding (Diluted Average) (2021 - 2026)

Erasca (ERAS) reported Shares Outstanding (Diluted Average) of $304.3 million for Q1 2026, up 7.43% on a YoY basis from $283.3 million in Q1 2025, and up 7.33% quarter-over-quarter from $283.5 million in Q4 2025.

Erasca (ERAS) Shares Outstanding (Diluted Average) (2021 - 2026) Analysis & Trends

Erasca has reported Shares Outstanding (Diluted Average) for 6 years, with the latest figure at $304.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 7.43% year-over-year to $304.3 million; the trailing twelve-month figure through Mar 2026 stood at $304.3 million (up 7.43% YoY), and the FY2025 full-year result was $283.5 million, up 21.26% from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2026 stood at $304.3 million, up from $283.5 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $304.3 million in Q1 2026, with the low at $119.5 million in Q1 2022.
  • Historically, Shares Outstanding (Diluted Average) has averaged $196.5 million across 5 years, with a median of $151.2 million in 2024.
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) surged 410.46% — and 2024, when it advanced 1.11%.
  • Erasca's Shares Outstanding (Diluted Average) stood at $122.0 million in 2022, then increased by 23.08% to $150.2 million in 2023, then surged by 55.69% to $233.8 million in 2024, then gained by 21.26% to $283.5 million in 2025, then increased by 7.33% to $304.3 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $304.3 million (Q1 2026), $283.5 million (Q4 2025), and $283.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 Erasca 4.16 Bn 3.92 Bn - 304.32 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 304.32 Mn
Dec 31, 2025 283.53 Mn
Sep 30, 2025 283.43 Mn
Jun 30, 2025 283.36 Mn
Mar 31, 2025 283.26 Mn
Dec 31, 2024 233.82 Mn
Sep 30, 2024 217.36 Mn
Jun 30, 2024 217.81 Mn
Mar 31, 2024 151.16 Mn
Dec 31, 2023 150.18 Mn
Sep 30, 2023 150.45 Mn
Jun 30, 2023 149.77 Mn
Mar 31, 2023 149.50 Mn
Dec 31, 2022 122.02 Mn
Sep 30, 2022 120.17 Mn
Jun 30, 2022 120.19 Mn
Mar 31, 2022 119.49 Mn
Dec 31, 2021 66.29 Mn
Sep 30, 2021 48.58 Mn
Jun 30, 2021 23.55 Mn